Earnings calendar/BBOT
BridgeBio Oncology Therapeutics Inc. (BBOT)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 11, 2026
Consensus estimate row
EPS target
$-0.54
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.55
Beat rate last 4: 50%
Latest EPS YoY
+98.6%
vs 2025-08-01
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS miss
EPS actual / est
$-0.71 / $-0.56
-24.8%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/11/2026upcoming | $-0.54 | Pending | — | — | Pending | — |
| 8/11/2026 | $-0.56 | $-0.71 | -24.8% | — | Pending | — |
| 6/4/2026 | $-0.51 | $-0.53 | -2.8% | — | Pending | — |
| 5/12/2026 | $-0.51 | $-0.48 | +6.3% | — | Pending | — |
| 3/5/2026 | $-0.63 | $-0.49 | +22.6% | — | Pending | — |
| 3/4/2026 | $-0.42 | $-0.56 | -33.3% | — | Pending | — |
| 2/25/2026upcoming | $-0.42 | Pending | — | — | Pending | — |
| 11/12/2025 | $-0.38 | $-1.03 | -169.8% | — | Pending | — |
| 8/1/2025 | $-42.45 | $-50.34 | -18.6% | — | Pending | — |
| 5/15/2025 | — | $-52.15 | — | — | Pending | — |
| 3/11/2025 | — | $0.12 | — | — | Pending | — |
| 11/14/2024 | — | $-0.74 | — | — | Pending | — |
| 8/14/2024 | — | $0.09 | — | — | Pending | — |
| 5/15/2024 | — | $0.05 | — | — | Pending | — |
| 12/31/2023 | — | $-0.00 | — | — | Pending | — |
| 12/30/2023 | — | $-0.00 | — | — | Pending | — |
| 12/31/2022 | — | $-0.00 | — | — | Pending | — |
| 12/30/2022 | — | $-0.00 | — | — | Pending | — |